| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycosphingolipid binding | 8.23e-05 | 13 | 135 | 3 | GO:0043208 | |
| GeneOntologyMolecularFunction | tubulin binding | TRAF3IP1 CEP295NL CEP290 TUBGCP2 CLIP1 CEP350 CCDC66 CCDC88A BRCA2 PAFAH1B1 LYN | 1.60e-04 | 428 | 135 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule binding | TRAF3IP1 CEP295NL CEP290 TUBGCP2 CLIP1 CEP350 CCDC66 CCDC88A PAFAH1B1 | 2.52e-04 | 308 | 135 | 9 | GO:0008017 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.17e-04 | 20 | 135 | 3 | GO:0061665 | |
| MousePheno | abnormal rod electrophysiology | 2.11e-06 | 119 | 100 | 8 | MP:0004021 | |
| Domain | GRIP_dom | 9.68e-07 | 12 | 127 | 4 | IPR000237 | |
| Domain | GRIP | 9.68e-07 | 12 | 127 | 4 | PS50913 | |
| Domain | Grip | 4.87e-05 | 11 | 127 | 3 | SM00755 | |
| Domain | GRIP | 4.87e-05 | 11 | 127 | 3 | PF01465 | |
| Domain | Ran_BP1 | 6.46e-05 | 12 | 127 | 3 | PF00638 | |
| Domain | RANBD1 | 6.46e-05 | 12 | 127 | 3 | PS50196 | |
| Domain | Cullin_repeat-like_dom | 6.46e-05 | 12 | 127 | 3 | IPR016159 | |
| Domain | RanBD | 8.35e-05 | 13 | 127 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 8.35e-05 | 13 | 127 | 3 | IPR000156 | |
| Domain | RmlC-like_jellyroll | 3.98e-04 | 51 | 127 | 4 | IPR014710 | |
| Domain | DOCK_N | 4.53e-04 | 5 | 127 | 2 | PF16172 | |
| Domain | DOCK_N | 4.53e-04 | 5 | 127 | 2 | IPR032376 | |
| Domain | Thiolase_acyl_enz_int_AS | 4.53e-04 | 5 | 127 | 2 | IPR020615 | |
| Domain | Thiolase_C | 6.76e-04 | 6 | 127 | 2 | PF02803 | |
| Domain | THIOLASE_2 | 6.76e-04 | 6 | 127 | 2 | PS00737 | |
| Domain | THIOLASE_1 | 6.76e-04 | 6 | 127 | 2 | PS00098 | |
| Domain | THIOLASE_3 | 6.76e-04 | 6 | 127 | 2 | PS00099 | |
| Domain | Thiolase_N | 6.76e-04 | 6 | 127 | 2 | IPR020616 | |
| Domain | Thiolase_C | 6.76e-04 | 6 | 127 | 2 | IPR020617 | |
| Domain | Thiolase_CS | 6.76e-04 | 6 | 127 | 2 | IPR020613 | |
| Domain | Thiolase | 6.76e-04 | 6 | 127 | 2 | IPR002155 | |
| Domain | Thiolase_N | 6.76e-04 | 6 | 127 | 2 | PF00108 | |
| Domain | TPR_REGION | 9.30e-04 | 165 | 127 | 6 | PS50293 | |
| Domain | TPR | 9.30e-04 | 165 | 127 | 6 | PS50005 | |
| Domain | Cullin_CS | 9.42e-04 | 7 | 127 | 2 | IPR016157 | |
| Domain | Rab_bind | 9.42e-04 | 7 | 127 | 2 | PF16704 | |
| Domain | CULLIN | 9.42e-04 | 7 | 127 | 2 | SM00182 | |
| Domain | GCC2_Rab_bind | 9.42e-04 | 7 | 127 | 2 | IPR032023 | |
| Domain | Ion_trans_dom | 1.09e-03 | 114 | 127 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.09e-03 | 114 | 127 | 5 | PF00520 | |
| Domain | Cullin_neddylation_domain | 1.25e-03 | 8 | 127 | 2 | IPR019559 | |
| Domain | Cullin_Nedd8 | 1.25e-03 | 8 | 127 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 1.25e-03 | 8 | 127 | 2 | SM00884 | |
| Domain | CNMP_BINDING_1 | 1.32e-03 | 32 | 127 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 1.32e-03 | 32 | 127 | 3 | PS00889 | |
| Domain | cNMP | 1.58e-03 | 34 | 127 | 3 | SM00100 | |
| Domain | cNMP_binding | 1.58e-03 | 34 | 127 | 3 | PF00027 | |
| Domain | Cullin_homology | 1.60e-03 | 9 | 127 | 2 | IPR016158 | |
| Domain | cNMP-bd_dom | 1.71e-03 | 35 | 127 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.71e-03 | 35 | 127 | 3 | PS50042 | |
| Domain | CAP_GLY | 1.99e-03 | 10 | 127 | 2 | PF01302 | |
| Domain | Cullin | 1.99e-03 | 10 | 127 | 2 | PF00888 | |
| Domain | CAP_GLY | 1.99e-03 | 10 | 127 | 2 | SM01052 | |
| Domain | - | 1.99e-03 | 10 | 127 | 2 | 2.30.30.190 | |
| Domain | - | 1.99e-03 | 10 | 127 | 2 | 3.40.47.10 | |
| Domain | CULLIN_2 | 1.99e-03 | 10 | 127 | 2 | PS50069 | |
| Domain | CAP_GLY_1 | 1.99e-03 | 10 | 127 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 1.99e-03 | 10 | 127 | 2 | PS50245 | |
| Domain | Thiolase-like | 1.99e-03 | 10 | 127 | 2 | IPR016039 | |
| Domain | CAP-Gly_domain | 1.99e-03 | 10 | 127 | 2 | IPR000938 | |
| Domain | Cullin_N | 1.99e-03 | 10 | 127 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 1.99e-03 | 10 | 127 | 2 | PS01256 | |
| Domain | - | 1.99e-03 | 10 | 127 | 2 | 1.10.220.60 | |
| Domain | cNMP-bd-like | 2.18e-03 | 38 | 127 | 3 | IPR018490 | |
| Domain | DHR-1_domain | 2.42e-03 | 11 | 127 | 2 | IPR027007 | |
| Domain | DHR_2 | 2.42e-03 | 11 | 127 | 2 | PS51651 | |
| Domain | DHR_1 | 2.42e-03 | 11 | 127 | 2 | PS51650 | |
| Domain | DHR-2 | 2.42e-03 | 11 | 127 | 2 | PF06920 | |
| Domain | DOCK | 2.42e-03 | 11 | 127 | 2 | IPR026791 | |
| Domain | DOCK_C | 2.42e-03 | 11 | 127 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 2.42e-03 | 11 | 127 | 2 | PF14429 | |
| Domain | DHR-2 | 2.42e-03 | 11 | 127 | 2 | IPR027357 | |
| Domain | TPR-contain_dom | 3.63e-03 | 150 | 127 | 5 | IPR013026 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 3.96e-03 | 14 | 127 | 2 | IPR003938 | |
| Domain | - | 4.25e-03 | 48 | 127 | 3 | 2.60.120.10 | |
| Domain | GATA_ZN_FINGER_1 | 5.17e-03 | 16 | 127 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 5.17e-03 | 16 | 127 | 2 | PS50114 | |
| Domain | TPR-like_helical_dom | 5.22e-03 | 233 | 127 | 6 | IPR011990 | |
| Pubmed | CUL4B PRPF31 RGPD8 CEP290 TNRC6B ARHGEF18 ICE1 TUBGCP2 CEP350 ZCCHC14 CCDC88A EIF4ENIF1 WDHD1 CEBPZ PHF3 ZNF451 PFDN6 | 6.67e-09 | 733 | 139 | 17 | 34672954 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CUL4B DOCK4 TCP1 CEP290 RGPD1 TNRC6B TUBGCP2 BIN3 CLIP1 CEP350 CCDC66 CCDC88A EIF4ENIF1 BRCA2 TSR1 LYN PFDN6 RAVER1 | 9.97e-09 | 853 | 139 | 18 | 28718761 |
| Pubmed | CAD RGPD8 TRAF3IP1 RGPD1 TNRC6B ARHGEF18 UPF1 HCN2 CLIP1 TRIP11 LETM1 CYRIB CCDC13 CCDC88A ERC2 CTNNA1 GOLGA3 AFF4 RAI1 | 1.10e-08 | 963 | 139 | 19 | 28671696 | |
| Pubmed | CUL4B DOCK4 CEP290 TRPS1 PSMD4 TUBGCP2 LETM1 CEP350 RIOX2 THADA WDHD1 PHF3 ZNF451 DENND4B PKP1 WDR48 | 1.88e-08 | 689 | 139 | 16 | 36543142 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL4B CUL4A PRPF31 SNRNP27 RGPD8 TRAF3IP1 TRPS1 RGPD1 TUBGCP2 CLIP1 CEP350 TSR1 ZNF451 PAFAH1B1 CTNNA1 PRKDC PFDN6 ANAPC5 RGPD5 RAVER1 | 3.79e-08 | 1155 | 139 | 20 | 20360068 |
| Pubmed | PSAP TRAF3IP1 ATRX CEP290 TRPS1 ZBTB47 PSMD4 TRIP11 FN3K PRKRA CEP350 CCDC13 ZNF451 ERC2 CTNNA1 PRKDC STAMBPL1 SNAP25 MED13 GOLGA3 AFF4 | 4.47e-08 | 1285 | 139 | 21 | 35914814 | |
| Pubmed | CUL4A CAD TCP1 TNRC6B PSMD4 UPF1 SERPINH1 PRKRA TSR1 CEBPZ PHF3 UCHL3 CTNNA1 PRKDC LYN PFDN6 MED13 AFF4 RAVER1 | 6.02e-07 | 1247 | 139 | 19 | 27684187 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 6.75e-07 | 123 | 139 | 7 | 26912792 | |
| Pubmed | CUL4B CUL4A PRPF31 CAD ATRX TCP1 TRPS1 UPF1 SERPINH1 RTF1 WDHD1 TSR1 PHF3 UCHL3 ZNF451 PRKDC MED13 | 6.79e-07 | 1014 | 139 | 17 | 32416067 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPF31 CAD TCP1 PSMD4 UPF1 PRKRA SLC25A12 WDHD1 UPF2 CEBPZ GYS1 PAFAH1B1 ACAA2 PRKDC | 9.75e-07 | 704 | 139 | 14 | 29955894 |
| Pubmed | SNRNP27 ZNF148 RGPD8 TRPS1 RGPD1 TNRC6B ICE1 CCDC88A EIF4ENIF1 BRCA2 GOLGA3 | 1.05e-06 | 418 | 139 | 11 | 34709266 | |
| Pubmed | CUL4A PRPF31 CAD TNRC6B PSMD4 UPF1 SERPINH1 RIOX2 WDHD1 UPF2 TSR1 CEBPZ ERC2 SHCBP1L PFDN6 ANAPC5 | 1.85e-06 | 971 | 139 | 16 | 33306668 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.16e-06 | 7 | 139 | 3 | 15710750 | |
| Pubmed | 2.63e-06 | 215 | 139 | 8 | 35973513 | ||
| Pubmed | 3.42e-06 | 298 | 139 | 9 | 30737378 | ||
| Pubmed | 3.69e-06 | 225 | 139 | 8 | 12168954 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CUL4A PRPF31 CAD TCP1 CARS1 TNRC6B MRPL28 UPF1 SERPINH1 LETM1 RTF1 TSR1 CEBPZ PKP1 AK2 CTNNA1 PRKDC AHNAK2 RAVER1 | 3.84e-06 | 1415 | 139 | 19 | 28515276 |
| Pubmed | PRPF31 SNRNP27 TRAF3IP1 TCP1 RGPD1 ARHGEF18 AK2 PFDN6 GOLGA3 AFF4 | 4.14e-06 | 390 | 139 | 10 | 17643375 | |
| Pubmed | 4.73e-06 | 396 | 139 | 10 | 26687479 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CUL4B CUL4A PRPF31 TRAF3IP1 ATRX CEP290 CLIP1 TRIP11 EXOC8 SLC9C1 THADA CCDC88A EIF4ENIF1 GYS1 PAFAH1B1 CTNNA1 WDR48 RAVER1 | 5.79e-06 | 1321 | 139 | 18 | 27173435 |
| Pubmed | DOCK4 TNRC6B ZCCHC14 MLC1 PHF3 ZNF451 DENND4B ERC2 ANKRD12 WDR48 | 6.02e-06 | 407 | 139 | 10 | 12693553 | |
| Pubmed | 6.11e-06 | 241 | 139 | 8 | 23125841 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | PRPF31 TNRC6B UPF1 PRKRA CEP350 RIOX2 EIF4ENIF1 UPF2 CEBPZ PHF3 AHNAK2 WDR48 RAVER1 | 7.30e-06 | 724 | 139 | 13 | 36232890 |
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 34685710 | ||
| Pubmed | ZNF148 ATRX MRPL28 PRKRA RTF1 CEP350 CCDC88A TSR1 CEBPZ AFF4 | 7.44e-06 | 417 | 139 | 10 | 36537216 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 8.16e-06 | 332 | 139 | 9 | 32786267 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CAD RGPD8 TCP1 MRPL28 PSMD4 UPF1 TRIP11 LETM1 IVD THADA SLC25A12 EIF4ENIF1 UPF2 SCP2 AK2 ACAA2 GOLGA3 AHNAK2 RAVER1 | 8.48e-06 | 1496 | 139 | 19 | 32877691 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | PRPF31 CAD TCP1 CEP290 TUBGCP2 CEP350 CCDC88A EIF4ENIF1 PKP1 PRKDC GOLGA3 RAVER1 | 1.07e-05 | 639 | 139 | 12 | 23443559 |
| Pubmed | CUL4A RNASEH2B CEP290 TNRC6B SERPINH1 CEP350 CCDC66 TSR1 SCP2 CDYL MED13 RAI1 | 1.17e-05 | 645 | 139 | 12 | 25281560 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PRPF31 CAD TCP1 MRPL28 UPF1 TUBGCP2 SERPINH1 PRKRA UPF2 TSR1 CEBPZ PHF3 PKP1 CTNNA1 PRKDC LYN RAVER1 | 1.18e-05 | 1257 | 139 | 17 | 36526897 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CUL4B CUL4A PRPF31 SNRNP27 PSMD4 ICE1 TUBGCP2 EXOC8 UCHL3 GYS1 PKP1 STAMBPL1 PFDN6 RGPD5 WDR48 | 1.28e-05 | 1005 | 139 | 15 | 19615732 |
| Pubmed | 1.33e-05 | 128 | 139 | 6 | 23858473 | ||
| Pubmed | TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A. | 1.46e-05 | 37 | 139 | 4 | 29531219 | |
| Pubmed | Modulation of RNA-binding properties of the RNA helicase UPF1 by its activator UPF2. | 1.59e-05 | 2 | 139 | 2 | 36456182 | |
| Pubmed | Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. | 1.59e-05 | 2 | 139 | 2 | 27974468 | |
| Pubmed | Molecular mechanisms for the RNA-dependent ATPase activity of Upf1 and its regulation by Upf2. | 1.59e-05 | 2 | 139 | 2 | 21419344 | |
| Pubmed | Discovery and characterization of potent And-1 inhibitors for cancer treatment. | 1.59e-05 | 2 | 139 | 2 | 34923765 | |
| Pubmed | Results of the determination of serum markers in patients with malignant melanoma. | 1.59e-05 | 2 | 139 | 2 | 17469741 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12897140 | ||
| Pubmed | Regulation of DNA-dependent protein kinase by the Lyn tyrosine kinase. | 1.59e-05 | 2 | 139 | 2 | 9748231 | |
| Pubmed | 4E-T-bound mRNAs are stored in a silenced and deadenylated form. | 1.59e-05 | 2 | 139 | 2 | 32354837 | |
| Pubmed | Unusual bipartite mode of interaction between the nonsense-mediated decay factors, UPF1 and UPF2. | 1.59e-05 | 2 | 139 | 2 | 19556969 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 20064923 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 25764135 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11940666 | ||
| Pubmed | Interaction between Ski7p and Upf1p is required for nonsense-mediated 3'-to-5' mRNA decay in yeast. | 1.59e-05 | 2 | 139 | 2 | 12881429 | |
| Pubmed | 1.74e-05 | 13 | 139 | 3 | 22724066 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | CUL4A CAD CEP290 OBSCN SERPINH1 SLC25A12 PAFAH1B1 PKP1 ERC2 ACAA2 PRKDC | 1.78e-05 | 564 | 139 | 11 | 21565611 |
| Pubmed | CAD TCP1 MRPL28 PSMD4 UPF1 TUBGCP2 SERPINH1 LETM1 CYRIB PRKRA THADA CEBPZ ACAA2 CTNNA1 PRKDC SNAP25 AHNAK2 RAVER1 | 1.85e-05 | 1440 | 139 | 18 | 30833792 | |
| Pubmed | CYLC1 RGPD8 ATRX RGPD1 CAGE1 LETM1 IVD SLC25A12 CEBPZ ERC2 KDR PRKDC DTHD1 MED13 RAI1 CFAP46 BAHCC1 RGPD5 | 1.88e-05 | 1442 | 139 | 18 | 35575683 | |
| Pubmed | CAD TCP1 CEP290 TRPS1 PSMD4 LETM1 CEP350 CCDC88A TSR1 CEBPZ AK2 CTNNA1 PFDN6 WDR48 RAVER1 | 2.11e-05 | 1049 | 139 | 15 | 27880917 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CUL4B CUL4A RNASEH2B PSAP TCP1 CARS1 PSMD4 SERPINH1 CLIP1 RTF1 WDHD1 TSR1 PAFAH1B1 ACAA2 CTNNA1 PRKDC PFDN6 AHNAK2 | 2.12e-05 | 1455 | 139 | 18 | 22863883 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 CAD RGPD8 ATRX TUBGCP2 SERPINH1 TRIP11 CCDC88A BRCA2 ZNF451 ERC2 | 2.61e-05 | 588 | 139 | 11 | 38580884 |
| Pubmed | CAD TCP1 ZBTB47 TNRC6B PSMD4 UPF1 SERPINH1 CLIP1 PRKRA CTNNA1 | 3.18e-05 | 494 | 139 | 10 | 26831064 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 3.64e-05 | 153 | 139 | 6 | 26365490 | |
| Pubmed | 3.90e-05 | 405 | 139 | 9 | 38187761 | ||
| Pubmed | 4.06e-05 | 156 | 139 | 6 | 22952844 | ||
| Pubmed | CUL4B CUL4A ZNF148 TRPS1 TNRC6B TUBGCP2 THADA SLC25A12 EIF4ENIF1 KMT5B ANAPC5 AFF4 RAI1 BAHCC1 WDR48 | 4.29e-05 | 1116 | 139 | 15 | 31753913 | |
| Pubmed | Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. | 4.75e-05 | 3 | 139 | 2 | 20923780 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 21671477 | ||
| Pubmed | Chromatoid Body Protein TDRD6 Supports Long 3' UTR Triggered Nonsense Mediated mRNA Decay. | 4.75e-05 | 3 | 139 | 2 | 27149095 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 15961404 | ||
| Pubmed | UPF1 helicase orchestrates mutually exclusive interactions with the SMG6 endonuclease and UPF2. | 4.75e-05 | 3 | 139 | 2 | 38709891 | |
| Pubmed | Dynamic regulation of TFH selection during the germinal centre reaction. | 4.75e-05 | 3 | 139 | 2 | 33536617 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 32587774 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 17803942 | ||
| Pubmed | Proteasome inhibitors and knockdown of SMG1 cause accumulation of Upf1 and Upf2 in human cells. | 4.75e-05 | 3 | 139 | 2 | 24173962 | |
| Pubmed | Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells. | 4.75e-05 | 3 | 139 | 2 | 37923359 | |
| Pubmed | RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. | 4.75e-05 | 3 | 139 | 2 | 35179959 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 28235840 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 17000771 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 34119472 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 19020519 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 31113933 | ||
| Pubmed | Macrophages prevent human red blood cell reconstitution in immunodeficient mice. | 4.75e-05 | 3 | 139 | 2 | 21926352 | |
| Pubmed | Cullin4B/E3-ubiquitin ligase negatively regulates beta-catenin. | 4.75e-05 | 3 | 139 | 2 | 17954973 | |
| Pubmed | E3 ubiquitin ligase Cullin4B mediated polyubiquitination of p53 for its degradation. | 4.75e-05 | 3 | 139 | 2 | 24452595 | |
| Pubmed | CUL4B DOCK4 ZNF148 CARS1 TRIP11 IVD SLC25A12 BRCA2 PKP1 CTNNA1 WDR48 | 5.16e-05 | 634 | 139 | 11 | 34591612 | |
| Pubmed | TRPS1 RGPD1 MRPL28 TRIP11 CEP350 WDHD1 GYS1 PFDN6 RAI1 AHNAK2 RAVER1 | 5.45e-05 | 638 | 139 | 11 | 31182584 | |
| Pubmed | 5.78e-05 | 19 | 139 | 3 | 17392787 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | CAD RGPD1 TNRC6B PSMD4 UPF1 SERPINH1 EXOC8 THADA SLC25A12 CTNNA1 PRKDC | 6.18e-05 | 647 | 139 | 11 | 26618866 |
| Pubmed | 6.34e-05 | 169 | 139 | 6 | 31462741 | ||
| Pubmed | CUL4B CAD UPF1 SERPINH1 PRKRA TSR1 CEBPZ PHF3 CTNNA1 PRKDC RAI1 | 6.71e-05 | 653 | 139 | 11 | 22586326 | |
| Pubmed | 6.95e-05 | 106 | 139 | 5 | 19394292 | ||
| Pubmed | Leukodystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 7.11e-05 | 55 | 139 | 4 | 24501781 | |
| Pubmed | DOCK2 CAD CEP290 TUBGCP2 EXOC8 LRP8 PRKRA CEP350 EIF4ENIF1 GYS1 SCP2 PRKDC STAMBPL1 MED13 GOLGA3 | 7.15e-05 | 1168 | 139 | 15 | 19946888 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.28e-05 | 341 | 139 | 8 | 32971831 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 8.06e-05 | 256 | 139 | 7 | 35777956 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 9.38e-05 | 59 | 139 | 4 | 28813667 | |
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 36384141 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 11544179 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 27941124 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 11113196 | ||
| Pubmed | Calcium-dependent interaction of Lis1 with IQGAP1 and Cdc42 promotes neuronal motility. | 9.47e-05 | 4 | 139 | 2 | 16369480 | |
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 30139844 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 21541368 | ||
| Pubmed | Elevated HMGN4 expression potentiates thyroid tumorigenesis. | 9.47e-05 | 4 | 139 | 2 | 28186538 | |
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 30945295 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 34420308 | ||
| Pubmed | 9.47e-05 | 4 | 139 | 2 | 10856712 | ||
| Interaction | DCAF4 interactions | CUL4B CUL4A TCP1 TNRC6B UPF1 DMXL1 PRKRA CEP350 EIF4ENIF1 CEBPZ PFDN6 WDR48 RAVER1 | 1.75e-06 | 378 | 136 | 13 | int:DCAF4 |
| Interaction | BRCA1 interactions | CUL4B DOCK4 CAD ZNF148 PSAP TCP1 OBSCN CARS1 ZBTB47 TNRC6B PSMD4 UPF1 SERPINH1 CLIP1 TRIP11 PRKRA CEP350 WDHD1 BRCA2 CTNNA1 PRKDC POLN WDR48 | 1.01e-05 | 1249 | 136 | 23 | int:BRCA1 |
| Interaction | DCAF4L1 interactions | 1.59e-05 | 23 | 136 | 4 | int:DCAF4L1 | |
| Interaction | POC1B interactions | 2.08e-05 | 83 | 136 | 6 | int:POC1B | |
| Interaction | NUP43 interactions | CUL4A RGPD8 TCP1 TNRC6B ICE1 CCDC168 RTF1 CCDC88A EIF4ENIF1 BRCA2 CEBPZ AK2 PFDN6 AHNAK2 RGPD5 | 2.16e-05 | 625 | 136 | 15 | int:NUP43 |
| Interaction | DUSP16 interactions | 3.39e-05 | 237 | 136 | 9 | int:DUSP16 | |
| GeneFamily | Cullins | 6.15e-04 | 8 | 86 | 2 | 1032 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CUL4B CUL4A ZNF148 ATRX TCP1 CEP290 TRPS1 CARS1 PSMD4 CLIP1 TRIP11 DMXL1 CEP350 RIOX2 UPF2 TSR1 UCHL3 DENND4B PAFAH1B1 SCP2 AK2 CDYL CTNNA1 PRKDC IQCE | 3.94e-09 | 1215 | 137 | 25 | M41122 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | DOCK4 ZNF148 ATRX ICE1 CEP350 ZCCHC14 WDHD1 PHF3 ZNF451 PAFAH1B1 CDYL | 5.43e-07 | 300 | 137 | 11 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 ZNF148 ATRX ATP8B1 CLIP1 CEP350 SLC25A12 WDHD1 UPF2 BRCA2 PHF3 ZNF451 PAFAH1B1 CDYL PLCB4 LYN MED13 | 2.52e-06 | 856 | 137 | 17 | M4500 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | TRAF3IP1 CEP290 CARS1 PSMD4 BCAS1 TUBGCP2 BIN3 ENO4 LRGUK THADA CCDC66 STPG1 STK33 DTHD1 ANAPC5 IQCE CFAP46 AHNAK2 | 1.64e-05 | 1093 | 137 | 18 | M41649 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | CUL4B ATRX CARS1 SERPINH1 S100A2 CCDC88A WDHD1 BRCA2 CEBPZ CDYL STAMBPL1 SNAP25 AFF4 AHNAK2 | 2.63e-05 | 721 | 137 | 14 | M10237 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | DOCK2 CUL4A RNASEH2B PRPF31 SNRNP27 CAD OBSCN ARHGEF18 ICE1 S100A2 ZCCHC14 UPF2 CEBPZ PHF3 CD47 PLCB4 PRKDC LY75 LYN PFDN6 | 3.86e-05 | 1394 | 137 | 20 | M9585 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | CUL4B CUL4A CAD ATRX TCP1 UPF1 PRKRA IVD EIF4ENIF1 KCNH2 CD47 SCP2 AK2 CDYL ACAA2 CTNNA1 PRKDC LYN ANAPC5 MED13 | 4.06e-05 | 1399 | 137 | 20 | M535 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CUL4B ZNF148 CEP290 CLIP1 TRIP11 DMXL1 CEP350 CCDC88A WDHD1 CEBPZ PHF3 SCP2 SNAP25 | 4.20e-05 | 656 | 137 | 13 | M18979 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | CUL4A RNASEH2B CAD TCP1 PRKRA WDHD1 BRCA2 TSR1 CEBPZ UCHL3 CD47 PRKDC PFDN6 ANAPC5 | 4.71e-05 | 761 | 137 | 14 | M11961 |
| Coexpression | GSE2706_UNSTIM_VS_2H_R848_DC_UP | 7.71e-05 | 195 | 137 | 7 | M4691 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 7.71e-05 | 195 | 137 | 7 | M7382 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 8.75e-05 | 199 | 137 | 7 | M5893 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | CUL4B CUL4A ATRX PRKRA CEP350 SLC25A12 UPF2 PHF3 PAFAH1B1 CTNNA1 | 8.98e-05 | 429 | 137 | 10 | M29 |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP | 9.03e-05 | 200 | 137 | 7 | M8860 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | CAD ZNF148 PSAP ATRX TNRC6B PSMD4 NRN1 DMXL1 ZCCHC14 KCTD14 AK2 ACAA2 EGFLAM SHCBP1L ANAPC5 WDR48 RAVER1 | 2.06e-05 | 822 | 136 | 17 | gudmap_developingGonad_e14.5_ testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | TRAF3IP1 ATRX CEP290 CLIP1 LETM1 CCDC66 CCDC88A BRCA2 CEBPZ PRKDC | 3.28e-05 | 311 | 136 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | TRAF3IP1 ATRX CEP290 TNRC6B CLIP1 LETM1 LRP8 CCDC66 CCDC88A BRCA2 CEBPZ ERC2 PRKDC ANAPC5 GOLGA3 AFF4 | 8.54e-05 | 831 | 136 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.56e-05 | 219 | 136 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#1_top-relative-expression-ranked_100 | 8.88e-05 | 14 | 136 | 3 | gudmap_developingKidney_e11.5_metaneph mesench_100_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.10e-04 | 291 | 136 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | ATRX CEP290 TNRC6B BCAS1 CLIP1 TRIP11 RTF1 CEP350 PHF3 ANKRD12 | 6.91e-10 | 199 | 138 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.06e-07 | 199 | 138 | 8 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.06e-07 | 199 | 138 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-06 | 176 | 138 | 7 | 87de432c680b80555342afac864599bbc002c040 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 176 | 138 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 182 | 138 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-06 | 184 | 138 | 7 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 185 | 138 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 187 | 138 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.42e-06 | 193 | 138 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 195 | 138 | 7 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-06 | 197 | 138 | 7 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.77e-06 | 197 | 138 | 7 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.77e-06 | 197 | 138 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.86e-06 | 198 | 138 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.96e-06 | 199 | 138 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-05 | 165 | 138 | 6 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-05 | 165 | 138 | 6 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 180 | 138 | 6 | cc31d2cd06161300b91b17a67bb432b75f0d719b | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.23e-05 | 182 | 138 | 6 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.52e-05 | 186 | 138 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 188 | 138 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 191 | 138 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 191 | 138 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 191 | 138 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.19e-05 | 194 | 138 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 3.28e-05 | 195 | 138 | 6 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.28e-05 | 195 | 138 | 6 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 3.28e-05 | 195 | 138 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-05 | 195 | 138 | 6 | 62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-05 | 195 | 138 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-05 | 195 | 138 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.28e-05 | 195 | 138 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 3.38e-05 | 196 | 138 | 6 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 3.38e-05 | 196 | 138 | 6 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.47e-05 | 197 | 138 | 6 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.47e-05 | 197 | 138 | 6 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 197 | 138 | 6 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | NS-critical-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.57e-05 | 198 | 138 | 6 | 72d51284d267f102c26f0ae8279ee9e11e69c7e3 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.67e-05 | 199 | 138 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.67e-05 | 199 | 138 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.67e-05 | 199 | 138 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.67e-05 | 199 | 138 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-05 | 200 | 138 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 3.78e-05 | 200 | 138 | 6 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 139 | 138 | 5 | 22a769d5195ed761ef333ef542746e1ba617a698 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-04 | 153 | 138 | 5 | 8bc09b8b1a32a8d7ac8201c626d2b306e7cc2972 | |
| Drug | Clorgyline | 8.36e-07 | 168 | 137 | 9 | ctd:D003010 | |
| Drug | Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.76e-06 | 194 | 137 | 9 | 2632_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.67e-05 | 185 | 137 | 8 | 4755_DN | |
| Drug | AC1NRAX5 | 1.74e-05 | 9 | 137 | 3 | CID005288137 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.95e-05 | 189 | 137 | 8 | 4271_DN | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; PC3; HT_HG-U133A | 2.35e-05 | 194 | 137 | 8 | 5826_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.35e-05 | 194 | 137 | 8 | 2779_DN | |
| Drug | 5194442; Up 200; 20uM; MCF7; HT_HG-U133A | 2.53e-05 | 196 | 137 | 8 | 6599_UP | |
| Drug | Pentoxifylline [6493-05-6]; Down 200; 14.4uM; HL60; HG-U133A | 2.53e-05 | 196 | 137 | 8 | 1444_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HG-U133A | 2.63e-05 | 197 | 137 | 8 | 1938_DN | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.63e-05 | 197 | 137 | 8 | 6792_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.72e-05 | 198 | 137 | 8 | 6596_UP | |
| Disease | endometriosis (biomarker_via_orthology) | 4.91e-05 | 16 | 134 | 3 | DOID:289 (biomarker_via_orthology) | |
| Disease | sarcoma (is_marker_for) | 2.03e-04 | 5 | 134 | 2 | DOID:1115 (is_marker_for) | |
| Disease | X-24020 measurement | 2.03e-04 | 5 | 134 | 2 | EFO_0022128 | |
| Disease | Prostate cancer, familial | 2.80e-04 | 69 | 134 | 4 | C2931456 | |
| Disease | smoking status measurement, triglyceride measurement | 3.03e-04 | 6 | 134 | 2 | EFO_0004530, EFO_0006527 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 4.24e-04 | 7 | 134 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Renal dysplasia and retinal aplasia | 4.24e-04 | 7 | 134 | 2 | cv:C0403553 | |
| Disease | Growth Disorders | 5.86e-04 | 36 | 134 | 3 | C0018273 | |
| Disease | chronotype measurement | CYLC1 SNRNP27 TRAF3IP1 TRPS1 TNRC6B CLIP1 WDHD1 KCNH2 PAFAH1B1 LRRTM4 PLCB4 SHCBP1L | 7.10e-04 | 882 | 134 | 12 | EFO_0008328 |
| Disease | gastritis | 7.22e-04 | 9 | 134 | 2 | EFO_0000217 | |
| Disease | Craniofacial Abnormalities | 7.48e-04 | 156 | 134 | 5 | C0376634 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.31e-03 | 12 | 134 | 2 | C0403553 | |
| Disease | cortex volume change measurement | 2.07e-03 | 15 | 134 | 2 | EFO_0021500 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.59e-03 | 60 | 134 | 3 | C4722327 | |
| Disease | Dystonia, Limb | 2.66e-03 | 17 | 134 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 2.66e-03 | 17 | 134 | 2 | C0393610 | |
| Disease | Dystonia, Paroxysmal | 2.99e-03 | 18 | 134 | 2 | C0393588 | |
| Disease | disease free survival | 2.99e-03 | 18 | 134 | 2 | EFO_0000409 | |
| Disease | neuroimaging measurement | TRPS1 RGPD1 TNRC6B LRP8 ENO4 THADA CCDC88A DENND4B ADAMTS18 ERC2 RAI1 BAHCC1 | 3.54e-03 | 1069 | 134 | 12 | EFO_0004346 |
| Disease | squamous cell carcinoma | 3.55e-03 | 67 | 134 | 3 | EFO_0000707 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.55e-03 | 67 | 134 | 3 | C3463824 | |
| Disease | mean reticulocyte volume | 3.60e-03 | 799 | 134 | 10 | EFO_0010701 | |
| Disease | Severe Combined Immunodeficiency | 3.69e-03 | 20 | 134 | 2 | C0085110 | |
| Disease | Malignant Glioma | 4.02e-03 | 70 | 134 | 3 | C0555198 | |
| Disease | mixed gliomas | 4.02e-03 | 70 | 134 | 3 | C0259783 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 4.36e-03 | 335 | 134 | 6 | EFO_0009931 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QAASKTDLKTFMGKA | 416 | Q96MC4 | |
| NKTCKALLMGDKDFS | 2251 | Q9P281 | |
| MDLKSSSKLKNGLTF | 661 | Q6ZSZ5 | |
| SSKLKNGLTFRKEDM | 666 | Q6ZSZ5 | |
| GNKKFLVESKKMSIS | 286 | Q63HQ2 | |
| CSGEMLKFTEKSLAK | 196 | Q8TC20 | |
| CLSDDASKAGMVKKK | 71 | Q5JRM2 | |
| EFKKMLKSTSDGLQI | 226 | Q7Z4H9 | |
| LKANSSMSEKITKSD | 911 | A2A2Z9 | |
| ACLSDLKKMESKDPG | 311 | Q8IYW2 | |
| SDCTLKKMDKEGKTL | 636 | Q6UB98 | |
| MTSLAQKICGKKTAF | 1286 | Q9Y485 | |
| IFAGADTKIMKNSGK | 311 | O43520 | |
| EMKCSEKGFQGKLIT | 1076 | Q8TE60 | |
| SNGHQSKSMLKDDLK | 371 | Q9UHB7 | |
| IKSTFVDGLLACMKK | 541 | Q7Z5Q5 | |
| KLMNSKKLSSTDCFK | 1411 | Q7Z5J4 | |
| MKKDSAARAKSDLLG | 181 | Q8IY67 | |
| EMKSGLKDFKTFLTN | 1196 | Q99666 | |
| EMKSGLKDFKTFLTN | 1196 | O14715 | |
| CKEKDGTISKLQTDM | 226 | Q6IPM2 | |
| SGKLLASCSADMTIK | 161 | P43034 | |
| AGKTANKLMDALKDS | 391 | Q9UJX4 | |
| DKSGKTALMHACLEK | 81 | A5PLL1 | |
| EMSKKLSDGTFKDSK | 311 | Q8TDR0 | |
| DGSSAMGRKCSKAKA | 326 | O15480 | |
| LKNFKGNKESTMICA | 326 | Q86VH4 | |
| NIFMGLDKIKKTACG | 66 | A6PVI3 | |
| DGMNSSKISIKLSKD | 736 | Q4FZB7 | |
| SGSELGKKLKATMDA | 56 | P54819 | |
| ATKGCLRALAMKFKT | 746 | Q12809 | |
| MALKNKAAKGSATKD | 271 | O95202 | |
| GMTLLKSSKTNSDKF | 1001 | Q8IVV2 | |
| MKSLSVSSDFLGKDK | 1711 | Q3V6T2 | |
| KDLSKSMSGRQKLEA | 21 | O15212 | |
| MSSKKTTFNEKGEKA | 581 | P35663 | |
| KRKGEKLNDASSDKM | 486 | O60449 | |
| CQKLDKSFSMIKEGD | 316 | P14151 | |
| KGFSDCLLKLGDSMA | 36 | Q9NPD7 | |
| SFLQKMADKILSTGK | 441 | Q9BSJ2 | |
| EKSGKDSLVSMKCSL | 731 | Q96M69 | |
| KELDIKDSKLGSSMN | 166 | O15083 | |
| MKSKEGRGKALSTCA | 226 | A6NET4 | |
| KKLDKLGMRGSNTCE | 241 | P26440 | |
| LGKLKEEMKSCGVSN | 586 | Q8IYI6 | |
| LGSDLTSAQKEMKTK | 981 | Q08378 | |
| KDNKLKSMSLATAGS | 251 | P09067 | |
| DGKKLSSSSKVCMEA | 926 | Q5VST9 | |
| VMCKKAAKAGLSQSL | 681 | Q92900 | |
| SMKEDGCNSSDKRLK | 1116 | P46100 | |
| CSSKGTLSKEMNKEL | 1196 | Q9Y2F5 | |
| RASMLEDSGSKKKFK | 606 | A0AVK6 | |
| SLESKDKGEKNFAMS | 516 | Q92608 | |
| FFKTMLASKSAEEGK | 1806 | Q92608 | |
| DSGKEAKNMSDSGKL | 1771 | Q8N1I0 | |
| SDALNSAIDKMTKKT | 361 | P35221 | |
| AQMTSKSCKGEKEID | 3246 | P51587 | |
| LSSRKNMDLAKSGIK | 181 | Q9Y232 | |
| LKKASGILTSEKMAN | 2151 | O15078 | |
| SASVDAEKSMLSKLK | 466 | Q13619 | |
| AEKSMLSKLKHECGA | 471 | Q13619 | |
| SKKNRLLMAESEGAK | 141 | Q8IYE1 | |
| KKSTDADLAMSKSAV | 46 | Q9NQY0 | |
| EGCMKKISSVNLDKL | 6 | Q4G0S7 | |
| KGEKNGMTFSSTKDL | 81 | A2RUB6 | |
| ILDMSDGKVGESSKK | 2241 | Q5VT06 | |
| FTVTKKGLALKSSMD | 306 | Q6ZMT9 | |
| MGCIKSKGKDSLSDD | 1 | P07948 | |
| KSAFNKLASSMGKEE | 1456 | O75064 | |
| CGKSSSGKLNLMKEV | 286 | A6NNW6 | |
| EKKLGMDSADSSSQK | 486 | Q9ULL0 | |
| GAFAKTSKIDMKGCI | 271 | Q9NUQ9 | |
| QEGKGKSSMKLTNLC | 3711 | Q8NDH2 | |
| LLKGDASLKMDKSDA | 91 | Q08722 | |
| ALKRTLDSMNSKGCK | 86 | P13807 | |
| KEGSSKDKKSAAEMN | 496 | O75363 | |
| MGSLASQATKDGKKD | 356 | P55036 | |
| TLALNFGSTLMKKKS | 111 | Q8N1S5 | |
| VLTKGNKEMKLSDGS | 591 | Q9UL51 | |
| EKSMLSKLKHECGAA | 626 | Q13620 | |
| KASSEGKSEMKKLRQ | 781 | P30622 | |
| KGSKQQCLMALDTFK | 276 | Q03701 | |
| EMDLLTKNCKAAAGK | 406 | Q14114 | |
| EMKSGLKDFKTFLTN | 1181 | P0DJD0 | |
| GELTKFKMFTKNDTL | 671 | Q9HAU5 | |
| TYLNLMGKSKKDATL | 551 | Q13835 | |
| MGKSKKDATLEACAG | 556 | Q13835 | |
| GAKDLVCSKMSRAKD | 76 | Q96Q06 | |
| MSKGQGKDKDLNSKS | 636 | Q92541 | |
| MKLSKTAVHFQDSGK | 811 | Q6YHU6 | |
| MADSGLDKKSTKCPD | 1 | Q9BYT3 | |
| TIAGCKMSKSLKNFI | 401 | P49589 | |
| KGGSNCLEMKKETEI | 986 | Q15147 | |
| ELKMTGLQGKVAKCS | 91 | A8MWV9 | |
| FGEKKGKCMSLDTIK | 551 | Q4G0N8 | |
| LMGFASFDSTKGKKV | 106 | Q8WVK2 | |
| LKMKSLSSQASKLGE | 91 | Q9H479 | |
| DKNKADLSRMSGKKD | 331 | P50454 | |
| KRASSGDKKDDKMLF | 611 | Q9BZQ2 | |
| CLDFSLQKTKMKLGV | 236 | P17987 | |
| TGKKMAKLCDLNKTS | 516 | P49221 | |
| AFKMSDSATKKLIGE | 221 | Q9UHV7 | |
| GSKLAEMFSSLAKAS | 56 | Q9BQ13 | |
| FEKMSKGSLGIKFSD | 121 | P22307 | |
| MKEAEKNLTDLGKFC | 71 | P60880 | |
| KKDGDMTAFNKLVST | 476 | Q9NRA8 | |
| LADKGVTAKDSKFKM | 2636 | Q8IVF2 | |
| FALKDKSKSGMISGL | 166 | O75746 | |
| SGALKKAGLSLKDMD | 301 | P42765 | |
| KKKDFSSKGAEDNMV | 506 | Q9UHF7 | |
| LFSRKEECSKHMSGK | 261 | Q9Y4E5 | |
| NNKDKMHFESGSTLK | 106 | P15374 | |
| CAKKKSGLVMILFSA | 66 | Q5HYL7 | |
| MKCSFDGKLKSQDTV | 751 | Q2NL82 | |
| CGKASNSSSKLMEHK | 286 | Q8N7Q3 | |
| GAKTLKKDRLSASDM | 576 | Q8TAF3 | |
| LAKVDKSGMKSIDTF | 286 | Q5TBB1 | |
| TLMSCFKSKTNRGLK | 206 | Q5TH74 | |
| LDNMGKSSKKSTALS | 936 | O75717 | |
| LTNAGMLEVSACKKK | 391 | Q96FJ0 | |
| SSMAEFLKVKGEKSG | 481 | Q8WWY3 | |
| DGRLKMKKSSDVAFT | 6 | Q5GH76 | |
| GDKTMECEKLGLSKH | 796 | Q92576 | |
| LKTPKEDLCSKFGMD | 146 | Q13084 | |
| AFDKMCSKLPKSLSE | 341 | P07602 | |
| ETCGKSFKRSMSLKV | 551 | Q9UFB7 | |
| GTKELLSSDMKKDFI | 321 | Q8IUF8 | |
| SKFLRVSTKIGSCMK | 746 | P27708 | |
| DCGKAFTQKSTLKMH | 246 | Q6P3V2 | |
| SLFSGILKEMDKFKT | 2811 | P78527 | |
| ESFMETGKGASKKQA | 166 | O75569 | |
| EDLNKFESLTMGAKK | 331 | Q8WYQ9 | |
| KKLMSLANSSEGKVD | 1766 | Q15643 | |
| MLSESQLSDGKKFKC | 276 | Q8N0Z9 | |
| KLTASDTGKTCLMKA | 161 | Q8NET8 | |
| SCQEGDKFKLSKGEM | 21 | P29034 | |
| DLKTQSGSEMKKFLS | 276 | P35968 | |
| EKKSSGMDKESALDK | 321 | Q9UQR1 | |
| CGKAFSQKTSLKAHM | 381 | A8MT65 | |
| SKMDLSVGSLSDKKF | 1081 | Q9UPQ9 | |
| CGKAFNDSSTLMKHK | 941 | A6NN14 | |
| SKTCLKEEMAKGEAS | 21 | Q03721 | |
| CKKKKGSMSDSANIL | 171 | Q15049 |